Comparison of sodium-glucose cotransporter-2 (SGLT2) inhibitors to reduce cardiovascular and renal outcomes: a network meta-analysis of randomized controlled trials

被引：0
作者：
Kani, R. [1 ]
Watanabe, A. [2 ]
Miyamoto, Y. [3 ]
Kuno, T. [4 ]
机构：
[1] Kameda Med Ctr, Kamogawa, Japan
[2] Univ Tsukuba, Div Hosp Med, Ibaraki, Japan
[3] Ctr Dis Control & Prevent, Div Diabet Translat, Surveillance Econ & Stat Branch, Atlanta, GA USA
[4] Albert Einstein Coll Med, Div Cardiol, Montefiore Med Ctr, New York, NY USA
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Sodium-glucose cotransporter-2 inhibitors in acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials
    Meine, Matheus Coelho
    Santo, Paula
    de Oliveira, Fabiana Dolovitsch
    Marques, Gustavo Lenci
    Barboza, Joaquim Spadoni
    HEART FAILURE REVIEWS, 2025, 30 (01) : 219 - 226
  • [22] The effect of sodium-glucose cotransporter-2 inhibitors on cardiac structure remodeling and function: A meta-analysis of randomized controlled trials
    Fan, Gang
    Guo, Dian-Long
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 114 : 49 - 57
  • [23] Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
    Mantovani, Alessandro
    Petracca, Graziana
    Csermely, Alessandro
    Beatrice, Giorgia
    Targher, Giovanni
    METABOLITES, 2021, 11 (01) : 1 - 11
  • [24] Risk of volume reduction associated with sodium-glucose cotransporter-2 inhibitors treatment: a meta-analysis of randomized controlled trials
    Rong, X., I
    Li, X.
    Gou, Q.
    Chen, X. P.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1048 - 1048
  • [25] Clinical implications of current cardiovascular outcome trials with sodium glucose cotransporter-2 (SGLT2) inhibitors
    Lim, Soo
    Eckel, Robert H.
    Koh, Kwang Kon
    ATHEROSCLEROSIS, 2018, 272 : 33 - 40
  • [26] Cardiovascular Outcomes With the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes and Chronic Kidney Disease An Updated Meta-Analysis of Randomized Controlled Trials
    Malik, Aaqib H.
    Yandrapalli, Srikanth
    Goldberg, Michael
    Jain, Diwakar
    Frishman, William H.
    Aronow, Wilbert S.
    CARDIOLOGY IN REVIEW, 2020, 28 (03) : 116 - 124
  • [27] The Safety and Efficacy of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in Acute Myocardial Infarction: A Systematic Review and MetaAnalysis of Randomized Controlled Trials
    Jafar, Uzair
    Khan, Muhammad Sami
    Hashmi, Tallal Mushtaq
    Ijaz, Maryam
    Jehangir, Hanzala
    Jagani, Sanjna Devi
    Munawar, Irja
    Khalid, Ayesha
    Maqsood, Maham
    Akram, Muhammad Faiq
    Saeed, Usman
    Ahmad, Adeel
    CIRCULATION, 2024, 150
  • [28] Heart Failure Prognosis in Diabetic Patients on SGLT2 (Sodium-Glucose Cotransporter-2) Inhibitors: A Systematic Review and Meta-Analysis
    Nso, Nso
    Emmanuel, Kelechi
    Nassar, Mahmoud
    Ayinde, Hakeem
    CIRCULATION, 2021, 144
  • [29] THE EFFICACY AND SAFETY OF SODIUM-GLUCOSE COTRANSPORTER 2 (SGLT2) INHIBITORS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Alves, C.
    Penedones, A.
    Mendes, D.
    Batel Marques, F.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E123 - E124
  • [30] Influence of Sodium-Glucose Cotransporter-2 Inhibitors on Plasma Adiponectin in Patients with Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
    Wang, Yang
    Xia, Ning
    HORMONE AND METABOLIC RESEARCH, 2022, 54 (12) : 833 - 844
12345